Arcadia Biosciences Financial Overview
Arcadia Biosciences's market cap is currently $5.22M. The company's EPS TTM is $-0.848; its P/E ratio is -1.00; Arcadia Biosciences is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
